NCT06696131View on ClinicalTrials.gov

Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH)

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

January 15, 2027

Study Completion Date

December 31, 2027

Conditions
Intracerebral HemorrhageIntracranial HemorrhagesHemorrhagic Strokes
Interventions
DRUG

TNK

TNK will be delivered into the site of the intracerebral hemorrhage via a brain catheter.

All Listed Sponsors
lead

Gaurav Gupta, MD

OTHER